The role of Myosin Vb in Hepatocyte Protein Trafficking

肌球蛋白 Vb 在肝细胞蛋白质运输中的作用

基本信息

  • 批准号:
    10360533
  • 负责人:
  • 金额:
    $ 13.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-07 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Background and aims: Microvillus Inclusion Disease (MVID) is a form of congenital diarrhea caused by inactivating mutations in Myosin Vb (MYO5B). The available treatment options for individuals with MVID are either lifelong total parenteral nutrition or full intestinal transplantation. MVID patients frequently present with cholestasis. This cholestasis was previously thought to arise from prolonged administration of total parenteral nutrition. However, recent publications have described mutations in MYO5B that do not result in MVID, but instead patients have isolated cholestasis. Given the complex nature of MVID and the limited treatment options available, understanding the pathogenesis of cholestasis resulting from mutations in MYO5B represents an important scientific question which needs to be addressed. The central hypothesis of this research proposal is that mutations in MYO5B result in aberrant expression of apical/canalicular membrane transporters preventing the normal secretion of bile salts. We base our hypothesis on preliminary data generated from our mouse and pig models of MVID which demonstrate mislocalization of BSEP and other canalicular transporters. Our findings are mirrored by published reports from patients with mutations in MYO5B, demonstrating aberrant expression of the bile salt export protein (BSEP) in hepatocytes. To date, no experimental animal model has been used to define the mechanism of cholestasis in the setting of MVID. For this K01 Career Development Award, I propose the use of germline MYO5B KO mice, an MVID pig model and a novel mouse model of MYO5B point mutation to address deficits in apical transporters in hepatocytes that arise from mutations in MYO5B. Specific Aim 1 will define the function of MYO5B in maintaining hepatocyte polarity and homeostasis. Specific Aim 2 will determine the mechanism by which the C266R mutation in MYO5B contributes to cholestasis, but does not result in MVID. At the completion of these studies I expect to have elucidated the role of MYO5B in the regulation of protein trafficking in hepatocytes in vivo and in vitro. This proposal highlights the need for a better understanding of the function of MYO5B in hepatocytes with the ultimate goal of improving current therapeutic treatments for MVID. Long-term objective and aims: Being the recipient of a K01 Career Development Award would provide the mentorship, training and support necessary to achieve my goal of becoming an independent investigator. This research is well suited for the National Institute of Diabetes and Digestive and Kidney Diseases as it relates to digestive and liver disorders. Vanderbilt University Medical Center offers all of the scientific resources required to complete this proposal. I have assembled a group of renowned scientists to serve as my mentors and mentorship committee, and as collaborators. Additionally, I have developed a training plan to enhance my scientific repertoire, increase my publication record and secure independent funding. This will ensure success in securing an independent position to start a new laboratory by the completion of this award.
项目总结 背景和目的:微绒毛包涵体病(MVID)是一种先天性腹泻,由 肌球蛋白VB(MYO5B)的失活突变。对于MVID患者,可用的治疗方案包括 无论是终生全肠外营养还是全肠道移植。MVID患者经常出现 胆汁淤积症。这种胆汁淤积以前被认为是由于长时间的完全非肠道给药引起的。 营养。然而,最近的出版物描述了MYO5B基因的突变,这些突变不会导致MVID,但 相反,患者都是孤立的胆汁淤积症。鉴于MVID的复杂性质和有限的治疗选择 了解MYO5B基因突变导致的胆汁淤积症的发病机制具有重要意义 这是一个需要解决的重要科学问题。这项研究提案的中心假设是 MYO5B基因突变导致根尖/小管膜转运蛋白异常表达 胆盐的正常分泌。我们的假设是基于我们的鼠标产生的初步数据 显示BSEP和其他小管转运蛋白定位错误的MVID猪模型。我们的 已发表的MYO5B突变患者的报告也反映了这一发现,显示出异常 胆盐输出蛋白在肝细胞中的表达到目前为止,还没有实验动物模型 被用来定义MVID时的胆汁淤积机制。对于此K01职业发展 奖,我建议使用生殖系MYO5B KO小鼠,MVID猪模型和一种新的小鼠模型 MYO5B点突变解决肝细胞顶端转运蛋白缺陷的研究 MYO5B。具体目标1将确定MYO5B在维持肝细胞极性和 动态平衡。特异靶2将确定MYO5B中C266R突变的机制 有助于胆汁淤积,但不会导致MVID。在完成这些研究后,我预计将有 阐明MYO5B在体内外肝细胞蛋白转运调控中的作用。这 该提案强调了有必要更好地了解MYO5B在肝细胞中的功能 最终目标是改进目前MVID的治疗方法。长期目标和宗旨:成为 K01职业发展奖获得者将提供必要的指导、培训和支持 实现我成为一名独立调查员的目标。这项研究非常适合国家研究院 糖尿病、消化和肾脏疾病,因为它与消化和肝脏疾病有关。范德比尔特 大学医学中心提供完成这项提案所需的所有科学资源。我有过 召集了一群著名的科学家作为我的导师和导师委员会,并 合作者。此外,我还制定了一个训练计划,以增强我的科学技能,增加我的 出版记录和获得独立的资金。这将确保成功地获得独立的 在完成这项奖励后开始一个新的实验室的职位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amy C Engevik其他文献

Amy C Engevik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amy C Engevik', 18)}}的其他基金

Elucidating the role of Myosin 5b in intestinal inflammation
阐明肌球蛋白 5b 在肠道炎症中的作用
  • 批准号:
    10883872
  • 财政年份:
    2023
  • 资助金额:
    $ 13.35万
  • 项目类别:
The role of Myosin Vb in hepatocyte protein trafficking
肌球蛋白 Vb 在肝细胞蛋白质运输中的作用
  • 批准号:
    9806158
  • 财政年份:
    2019
  • 资助金额:
    $ 13.35万
  • 项目类别:
The role of Myosin Vb in Hepatocyte Protein Trafficking
肌球蛋白 Vb 在肝细胞蛋白质运输中的作用
  • 批准号:
    10401609
  • 财政年份:
    2019
  • 资助金额:
    $ 13.35万
  • 项目类别:
The role of Myosin Vb in Hepatocyte Protein Trafficking
肌球蛋白 Vb 在肝细胞蛋白质运输中的作用
  • 批准号:
    10581503
  • 财政年份:
    2019
  • 资助金额:
    $ 13.35万
  • 项目类别:
Deficits in Enterocyte Apical Transporters Associated with Loss of Myosin Vb
与肌球蛋白 Vb 丢失相关的肠细胞顶端转运蛋白缺陷
  • 批准号:
    9403155
  • 财政年份:
    2017
  • 资助金额:
    $ 13.35万
  • 项目类别:

相似海外基金

Building a Systems Approach to Community Health and Health Equity for Academic Medical Centers
为学术医疗中心建立社区健康和健康公平的系统方法
  • 批准号:
    9348616
  • 财政年份:
    2016
  • 资助金额:
    $ 13.35万
  • 项目类别:
Building a Systems Approach to Community Health and Health Equity for Academic Medical Centers
为学术医疗中心建立社区健康和健康公平的系统方法
  • 批准号:
    9212055
  • 财政年份:
    2016
  • 资助金额:
    $ 13.35万
  • 项目类别:
A CONFERENCE ON THE 'CRISIS' OF ACADEMIC MEDICAL CENTERS
关于学术医疗中心“危机”的会议
  • 批准号:
    6335654
  • 财政年份:
    2000
  • 资助金额:
    $ 13.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了